Masimo Corp. Stock
Masimo Corp. Stock
A loss of -1.530% shows a downward development for Masimo Corp..
Masimo Corp. is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
As a result the target price of 171 € shows a slightly positive potential of 10.43% compared to the current price of 154.85 € for Masimo Corp..
Pros and Cons of Masimo Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Masimo Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Masimo Corp. | -1.530% | 0.748% | 2.754% | 17.400% | 39.254% | -6.885% | -22.010% |
| Haemonetics Corp. | 0.820% | 5.106% | -12.566% | - | -27.883% | - | - |
| CONMED Corp. | -1.960% | 0.000% | -18.478% | -42.308% | -14.286% | -67.914% | -72.973% |
| Bio-Techne Corp. | -0.430% | 1.770% | -7.631% | -2.954% | -8.000% | -32.353% | - |
Comments
Masimo (NASDAQ:MASI) had its price target raised by analysts at BTIG Research from $198.00 to $200.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo (NASDAQ:MASI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $198.00 price target on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo (NASDAQ:MASI) had its price target lowered by analysts at Wells Fargo & Company from $190.00 to $187.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
News
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition
On February 17, 2026, Bridger Management disclosed in a Securities and Exchange Commission (SEC) filing that it sold out its entire position in Masimo (NASDAQ:MASI).
According to a Securities and
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
On February 17, 2026, Parkman Healthcare Partners disclosed a new position in Masimo Corporation (NASDAQ:MASI), acquiring 200,000 shares in the fourth quarter worth an estimated $26.01 million at
Naya Capital Adds Masimo Shares
According to an SEC filing dated Feb. 18, Naya Capital Management UK Ltd disclosed a new position in Masimo (NASDAQ:MASI), acquiring nearly 1.6 million shares.
Masimo is a leading provider of